ÎçÒ¹¸£Àû1000¼¯ºÏAlzheimer's drug lecanemab slows cognitive decline but concerns linger The drug lecanemab slowed the rate of cognitive decline among people with early Alzheimer's disease by 27 per cent, compared with placebo infusions, but some question if its potential safety concerns outweigh any benefits News
ÎçÒ¹¸£Àû1000¼¯ºÏStroke drug improves memory and repairs injured brain tissue in mice Unlike existing treatments that focus on rehabilitation or reducing the risk of an additional stroke, the experimental drug targets the "stickiness" that can prevent injured brain tissue from functioning as it should News